Detalles de la búsqueda
1.
Administration of docetaxel plus ramucirumab with primary prophylactic pegylated-granulocyte colony-stimulating factor for pretreated non-small cell lung cancer: a phase II study.
Support Care Cancer
; 28(10): 4825-4831, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31982960
2.
Metabolic activity by 18F-FDG-PET/CT is predictive of early response after nivolumab in previously treated NSCLC.
Eur J Nucl Med Mol Imaging
; 45(1): 56-66, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28828507
3.
Dramatic Response of S-1 Administration to Chemorefractory Advanced Thymic Cancer.
Chemotherapy
; 60(5-6): 356-9, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-26389778
4.
Pyrolysis and steam gasification properties of mangroves.
Chemosphere
; 345: 140388, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37816444
5.
Defossilization and decarbonization of hydrogen production using plastic waste: Temperature and feedstock effects during thermolysis stage.
J Hazard Mater
; 452: 131270, 2023 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36989781
6.
Comparative analysis of different response criteria at early phase after PD-1 blockade in non-small lung cancer.
Cancer Imaging
; 23(1): 23, 2023 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36859341
7.
Predictive significance of circulating tumor DNA against patients with T790M-positive EGFR-mutant NSCLC receiving osimertinib.
Sci Rep
; 13(1): 20848, 2023 11 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38012343
8.
Prospective assessment using 18F-FDG PET/CT as a novel predictor for early response to PD-1 blockade in non-small-cell lung cancer.
Sci Rep
; 12(1): 11832, 2022 07 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35821395
9.
Plasma plastin-3: A tumor marker in patients with non-small-cell lung cancer treated with nivolumab.
Oncol Lett
; 21(1): 11, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33240417
10.
Interstitial lung disease secondary to alectinib after interstitial injury induced by crizotinib.
J Cancer Res Ther
; 16(4): 919-921, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32930141
11.
Occurrence of Hematological Malignancy in Long-term Survivors With Advanced Thymic Cancer.
In Vivo
; 34(3): 1511-1513, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32354955
12.
Glasgow prognostic score predicts efficacy and prognosis in patients with advanced non-small cell lung cancer receiving EGFR-TKI treatment.
Thorac Cancer
; 11(8): 2188-2195, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32495520
13.
Prospective Feasibility Study of Amrubicin and Bevacizumab Therapy for Patients With Previously Treated Advanced NSCLC.
Anticancer Res
; 40(3): 1571-1578, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32132059
14.
Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.
Thorac Cancer
; 11(10): 2867-2876, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32844570
15.
Efficacy and safety of immune checkpoint inhibitor monotherapy in pretreated elderly patients with non-small cell lung cancer.
Cancer Chemother Pharmacol
; 85(4): 761-771, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32193618
16.
Direct analysis of saturated hydrocarbons using glow discharge plasma ionization source for mass spectrometry.
Talanta
; 204: 310-319, 2019 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31357299
17.
Removal of gaseous elemental mercury by hydrogen chloride non-thermal plasma modified biochar.
J Hazard Mater
; 377: 132-141, 2019 09 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31158582
18.
An Exploratory Randomized Phase II Trial Comparing CDDP Plus S-1 With Bevacizumab and CDDP Plus Pemetrexed With Bevacizumab Against Patients With Advanced Non-squamous Non-small Cell Lung Cancer.
Anticancer Res
; 39(5): 2483-2491, 2019 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-31092443
19.
Altered signaling pathway in the dysmorphogenesis of telencephalon in the Gli3 depressed mouse embryo, Pdn/Pdn.
Congenit Anom (Kyoto)
; 48(2): 74-80, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-18452488
20.
A phase II study of afatinib treatment for elderly patients with previously untreated advanced non-small-cell lung cancer harboring EGFR mutations.
Lung Cancer
; 126: 41-47, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30527191